Hirose, Satoshi
Hara, Makoto http://orcid.org/0000-0001-8893-6847
Kamei, Satoshi
Dalmau, Josep
Nakajima, Hideto
Article History
Received: 31 March 2021
Revised: 7 August 2021
Accepted: 27 September 2021
First Online: 6 October 2021
Declarations
:
: Josep Dalmau receives royalties from Athena Diagnostics for the use of Ma2 as an autoantibody test and from Euroimmun for the use of NMDA receptor, GABAB receptor, GABAA receptor, DPPX and IgLON5 as autoantibody tests. Satoshi Hirose, Makoto Hara, Satoshi Kamei and Hideto Nakajima report no disclosures relevant to the manuscript.
: This study was approved by the ethics committee of the Nihon University School of Medicine.
: Written informed consent for participation was obtained from the patients or their family members.
: Written informed consent for participation was obtained from the patients or their family members.